These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice. Raynaud FI, Boxall FE, Goddard PM, Valenti M, Jones M, Murrer BA, Abrams M, Kelland LR. Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598 [Abstract] [Full Text] [Related]
4. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. Ronconi L, Giovagnini L, Marzano C, Bettìo F, Graziani R, Pilloni G, Fregona D. Inorg Chem; 2005 Mar 21; 44(6):1867-81. PubMed ID: 15762713 [Abstract] [Full Text] [Related]
5. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin. Calamai P, Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P, Speroni GP. Anticancer Drug Des; 1998 Jan 21; 13(1):67-80. PubMed ID: 9474243 [Abstract] [Full Text] [Related]
6. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand. Marzano C, Pellei M, Colavito D, Alidori S, Lobbia GG, Gandin V, Tisato F, Santini C. J Med Chem; 2006 Dec 14; 49(25):7317-24. PubMed ID: 17149861 [Abstract] [Full Text] [Related]
7. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I). Caruso F, Rossi M, Tanski J, Pettinari C, Marchetti F. J Med Chem; 2003 Apr 24; 46(9):1737-42. PubMed ID: 12699391 [Abstract] [Full Text] [Related]
8. In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride. Pillarsetty N, Katti KK, Hoffman TJ, Volkert WA, Katti KV, Kamei H, Koide T. J Med Chem; 2003 Mar 27; 46(7):1130-2. PubMed ID: 12646023 [Abstract] [Full Text] [Related]
9. Cytotoxic activity of some gold(III) complexes. Cossu F, Matovic Z, Radanovic D, Ponticelli G. Farmaco; 1994 Apr 27; 49(4):301-2. PubMed ID: 8049012 [Abstract] [Full Text] [Related]
10. New platinum, titanium, and ruthenium complexes with different patterns of DNA damage in rat ovarian tumor cells. Frühauf S, Zeller WJ. Cancer Res; 1991 Jun 01; 51(11):2943-8. PubMed ID: 2032232 [Abstract] [Full Text] [Related]
11. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR. Anticancer Res; 1996 Jun 01; 16(1):33-8. PubMed ID: 8615631 [Abstract] [Full Text] [Related]
12. In vitro antitumour and hepatotoxicity profiles of Au(I) and Ag(I) bidentate pyridyl phosphine complexes and relationships to cellular uptake. Liu JJ, Galettis P, Farr A, Maharaj L, Samarasinha H, McGechan AC, Baguley BC, Bowen RJ, Berners-Price SJ, McKeage MJ. J Inorg Biochem; 2008 Feb 01; 102(2):303-10. PubMed ID: 18029019 [Abstract] [Full Text] [Related]
13. SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity. Hartley JA, Spanswick VJ, Brooks N, Clingen PH, McHugh PJ, Hochhauser D, Pedley RB, Kelland LR, Alley MC, Schultz R, Hollingshead MG, Schweikart KM, Tomaszewski JE, Sausville EA, Gregson SJ, Howard PW, Thurston DE. Cancer Res; 2004 Sep 15; 64(18):6693-9. PubMed ID: 15374986 [Abstract] [Full Text] [Related]
14. In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride. Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung CM, Mong SM, Sadler PJ, Crooke ST. Cancer Res; 1986 Nov 15; 46(11):5486-93. PubMed ID: 3756897 [Abstract] [Full Text] [Related]
15. Stabilization of gold(I) and gold(III) complexes by pyridil bis{3-hexamethylene-iminylthiosemicarbazone}: spectroscopic, structural and computational study. Castiñeiras A, Dehnen S, Fuchs A, García-Santos I, Sevillano P. Dalton Trans; 2009 Apr 21; (15):2731-9. PubMed ID: 19333496 [Abstract] [Full Text] [Related]
16. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts. Pratesi G, De Cesare M, Carenini N, Perego P, Righetti SC, Cucco C, Merlini L, Pisano C, Penco S, Carminati P, Vesci L, Zunino F. Clin Cancer Res; 2002 Dec 21; 8(12):3904-9. PubMed ID: 12473606 [Abstract] [Full Text] [Related]
17. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A, Iakovou K, Gikas E, Fichtner I, Fiebig HH, Kelland LR, Double JA, Bibby MC, Hendriks HR. Anticancer Res; 2004 Dec 21; 24(2B):907-19. PubMed ID: 15161044 [Abstract] [Full Text] [Related]
18. Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Yamori T, Matsunaga A, Sato S, Yamazaki K, Komi A, Ishizu K, Mita I, Edatsugi H, Matsuba Y, Takezawa K, Nakanishi O, Kohno H, Nakajima Y, Komatsu H, Andoh T, Tsuruo T. Cancer Res; 1999 Aug 15; 59(16):4042-9. PubMed ID: 10463605 [Abstract] [Full Text] [Related]
19. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models. Hoch U, Lynch J, Sato Y, Kashimoto S, Kajikawa F, Furutani Y, Silverman JA. Cancer Chemother Pharmacol; 2009 Jun 15; 64(1):53-65. PubMed ID: 18931998 [Abstract] [Full Text] [Related]
20. Potential new antitumor agents from an innovative combination of camphorato, a ramification of traditional Chinese medicine, with a platinum moiety. Wang L, Gou S, Chen Y, Liu Y. Bioorg Med Chem Lett; 2005 Jul 15; 15(14):3417-22. PubMed ID: 15953727 [Abstract] [Full Text] [Related] Page: [Next] [New Search]